Skip to content
Screener

West Pharmaceutical Services WST Other European countries — Long-Lived Assets

Similar metrics at other companies

Terex logo
TEXOther European countries — Long-Lived Assets
$63M-6.0%
Cimpress plc logo
CMPROther Countries — Long-Lived Assets
$59.21M-44.0%
Applied Industrial Technologies logo
AITOther Countries — Long-Lived Assets
$14.36M-6.7%
Graco logo
GGGOther countries — Long-Lived Assets
$157.36M+7.1%
LKQ logo
LKQOther countries — Long-Lived Assets
$762M+5.0%
Workiva logo
WKOther countries — Long-Lived Assets
$2.8M

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24.7B+44.8%
Enterprise value$24.58B+45.8%
P/E43.7×+8.7×
P/S7.4×+1.7×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The source filing: West Pharmaceutical Services’s 10-K, filed February 17, 2026.

Filed
Feb 17, 2026, 4:28 PM EST
Fiscal year
FY2025
Accession
0000105770-26-000010
($ in millions)Net Sales / 2025Net Sales / 2024Net Sales / 2023Long-Lived Assets / 2025Long-Lived Assets / 2024
United States$1,329.6$1,230.8$1,238.5$834.7$832.0
Germany380.3372.5406.1233.2191.1
Ireland333.3323.2285.7366.3299.6
France226.6242.2282.9113.384.7
Other European countries451.0385.5388.1108.798.1
Other353.3339.0348.5221.9210.3
$3,074.1$2,893.2$2,949.8$1,878.1$1,715.8

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is West Pharmaceutical Services's other european countries — long-lived assets?
West Pharmaceutical Services (WST) reported other european countries — long-lived assets of $108.7M in Q4 2025.
How has West Pharmaceutical Services's other european countries — long-lived assets changed year-over-year?
West Pharmaceutical Services's other european countries — long-lived assets increased by 10.8% year-over-year, from $98.1M to $108.7M.
What does other european countries — long-lived assets mean?
This metric measures the total value of non-current, tangible, and intangible assets held by the company within the specified European geographic segment. It encompasses investments in manufacturing facilities, regional distribution infrastructure, and other long-term capital holdings essential for regional operations. Monitoring this balance provides insight into the company's long-term capital commitment and physical footprint in these markets.

Ask your AI about West Pharmaceutical Services's other european countries — long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude